Chronic rhinosinusitis with nasal polyps (CRSwNP) is one of the most frequently encountered chronic nasal diseases with a significant impact on patient quality of life. The aim of our study was therefore to investigate the association between the POSTN, IL-4, and IL-13 gene expression and the nasal polyp development. The objective of this study was to determine differential expression of POSTN, IL-4, and IL-13 genes in the mucosa and polyps of 63 patients with CRSwNP and 23 chronic rhinosinusitis (CRS) without nasal polyps (CRSsNP) when compared with patients with nasal septum deviation (n=18) who were used as controls. The expression level was investigated using reverse transcription–polymerase chain reaction assays in the polyp tissue and the mucosa of paranasal sinus collected while undergoing functional endoscopic sinus surgery. Expression of the mRNAs of all three genes, IL-4, IL-13, and POSTN, was significantly greater in the paired tissues of CRS patients with NPs or without NPs than in control subjects, with highest levels of POSTN and IL-13 seen in CRSwNP. An increased level of POSTN, IL-4, and IL-13 gene expression may be related to the development of chronic rhinosinusitis with nasal polyps, but polyp formation seemed to be associated especially with POSTN and IL-13 expression.
Get full access to this article
View all access options for this article.
References
1.
al GhamdiK., GhaffarO., SmallP., FrenkielS., and HamidQ. (1997). IL-4 and IL-13 expression in chronic sinusitis: relationship with cellular infiltrate and effect of topical corticosteroid treatment. J Otolaryngol, 26, 160–166.
2.
AyersC.M., SchlosserR.J., O'ConnellB.P., AtkinsonC., MulliganR.M., CaseyS.E., et al. (2011). Increased presence of dendritic cells and dendritic cell chemokines in the sinus mucosa of chronic rhinosinusitis with nasal polyps and allergic fungal rhinosinusitis. Int Forum Allergy Rhinol, 1, 296–302.
3.
BachertC., GevaertP., HoltappelsG., et al. (2000). Nasal polyposis: from cytokines to growth. Am J Rhinol, 14, 279–290.
4.
BergerG., KattanA., BernheimJ., et al. (2002). Polypoid mucosa with eosinophilia and glandular hyperplasia in chronic rhinosinusitis: a histopathological and immunohistochemical study. Laryngoscope, 112, 738–745.
5.
BhaktaN.R., and WoodruffP.G. (2011). Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol Rev, 242, 220–232.
6.
BlanchardC., et al. (2008). Periostin facilitates eosinophil tissue infiltration in allergic lung and esophageal responses. Mucosal Immunol, 1, 289–296.
7.
ConwayS.J., DoetschmanT., and AzharM. (2011). The interrelationship of periostin, TGF beta, and BMP in heart valve development and valvular heart diseases. Sci World J, 11, 1509–1524.
8.
DainesS.M., WangY., and OrlandiR.R. (2011). Periostin and osteopontin are overexpressed in chronically inflamed sinuses. Int Forum Allergy Rhinol, 1, 101–105.
9.
HamilosD.L., LeungD.Y., WoodR., CunninghamL., BeanD.K., YasruelZ., SchotmanE., and HamidQ. (1995). Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol, 96, 537–544.
10.
HuvenneW., Van BruaeneN., ZhangN., et al. (2009). Chronic rhinosinusitis with and without nasal polyps: what is the difference?. Curr Allergy Asthma Rep, 9, 213–220.
11.
IshidaA., OhtaN., SuzukiY., et al. (2012). Expression of pendrin and periostin in allergic rhinitis and chronic rhinosinusitis. Allergol Int, 61, 589–595.
12.
JiaG., EricksonR.W., ChoyD.F., et al. (2012). Asthma and lower airways disease: periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol, 130, 647–654.
13.
KamilA., GhaffarO., LavigneF., TahaR., RenziP.M., and HamidQ. (1998). Comparison of inflammatory cell profile and Th2 cytokine expression in the ethmoid sinuses, maxillary sinuses, and turbinates of atopic subjects with chronic sinusitis. Otolaryngol Head Neck Surg, 118, 804–809.
14.
KanemitsuY., MatsumotoH., IzuharaK., et al. (2013). Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids. J Allergy Clin Immunol, 132, 305–312.
15.
KudoA. (2011). Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci, 68, 3201–3207.
16.
KumagaiN., FukudaK., FujitsuY., and NishidaT. (2003). Synergistic effect of TNF-alpha and either IL-4 or IL-13 on VCAM-1 expression by cultured human corneal fibroblasts. Cornea, 22, 557–561.
17.
MasuokaM., ShiraishiH., OhtaS.I., et al. (2012). Periostin promotes chronic allergic inflammation in response to Th2 cytokines. J Clin Invest, 122, 2590–2600.
18.
NabaviM., ArshiS., BahramiA., AryanZ., BemanianM.H., EsmaeilzadehH., JalaliF., PoustiS.B., and RezaeiN. (2014). Increased level of interleukin-13, but not interleukin-4 and interferon-γ in chronic rhinosinusitis with nasal polyps. Allergol Immunopathol (Madr), 42, 465–471.
19.
NishiyamaT., et al. (2011). Delayed re-epithelialization in periostin-deficient mice during cutaneous wound healing. PLoS One, 6, e18410.
20.
NorrisR.A., DamonB., MironovV., et al. (2007). Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues. J Cell Biochem, 101, 695–711.
21.
PawankarR. (2001). Mast cells as orchestrators of the allergic reaction: the IgE-IgE mast cell network. Curr Opin Allergy Clin Immunol, 1, 3–6.
22.
PietruszewskaW., OlejniczakI., DurkoT., and MłynarskiW. [Role of IFN-gamma and TNF-alpha in etiology of nasal polyps—initial studies] (Article in Polish). Otolaryngol Pol, 62, 54–58.
23.
ProvostV., LangloisA., ChouinardF., Rola-PleszczynskiM., ChakirJ., FlamandN., et al. (2012). Leukotriene D4 and interleukin-13 cooperate to increase the release of eotaxin-3 by airway epithelial cells. PLoS One, 7, e43544.
24.
RiechelmannH., DeutschleT., RozsasiA., KeckT., PolzehlD., and BürnerH. (2005). Nasal biomarker profiles in acute and chronic rhinosinusitis. Clin Exp Allergy, 35, 1186–1191.
25.
RiosH., et al. (2005). Periostin null mice exhibit dwarfism incisor enamel defects, and an early-onset periodontal disease-like phenotype. Mol Cell Biol, 25, 11131–11144.
26.
RomanosG.E., AsnaniK.P., HingoraniD., and DeshmukhV.L. (2014). Periostin: role in formation and maintenance of dental tissues. J Cell Physiol, 229, 1–5.
27.
SidhuS.S., et al. (2010). Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A, 107, 14170–14175.
28.
StankovicK.M., GoldszteinH., RehD.D., et al. (2008). Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma. Laryngoscope, 118, 881–889.
29.
SteinkeJ.W., PayneS.C., and BorishL. (2012). Interleukin-4 in the generation of the AERD phenotype: implications for molecular mechanisms driving therapeutic benefit of aspirin desensitization. J Allergy (Cairo), 2012, 182090.
30.
TakayamaG., ArimaK., KanajiT., et al. (2006). Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of Il-4 and Il-13 signals. J Allergy Clin Immunol, 118, 98–104.
31.
TosM., LarsenP.L., LarsenK., and Caye-ThomasenP. (2010). Pathogenesis and pathophysiology of nasal polyps. In Nasal Polypositas. OnerciT.M. and FergusonB.J., eds. (Springer-Verlag, Berlin), pp. 53–64.
32.
UchidaM., et al. (2012). Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol, 46, 677–686.
33.
Van BruaeneN., DeryckeL., Perez-NovoC.A., et al. (2009). TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol, 124, 253–259; 259.e1–e259.e2.
34.
Van BruaeneN., Perez-NovoC.A., BasinskiT.M., Van ZeleT., HoltappelsG., De RuyckN., et al. (2008). T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol, 121, 1435–1441.
35.
van ZeleT., ClaeysS., GevaertP., et al. (2006). Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy, 61, 1280–1289.
36.
WateletJ.B., BachertC., ClaeysC., and Van CauwenbergeP. (2004). Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: expression in chronic sinusitis vs nasal polyposis. Allergy, 59, 54–60.
37.
WenW., ChauE., Jackson-BoetersL., et al. (2010). TGF-beta 1 and FAK regulate periostin expression in PDL fibrosis. J Dent Res, 89, 1439–1443.
38.
WiseS.K., Den BesteK.A., HoddesonE.K., ParkosC.A., and NusratA. (2013). Sinonasal epithelial wound resealing in an in vitro model: inhibition of wound closure with IL-4 exposure. Int Forum Allergy Rhinol, 3, 439–449.
39.
ZhangW., HubinG., EndamL.M., Al-MotS., Filali-MouhimA., and DesrosiersM. (2012). Expression of the extracellular matrix gene periostin is increased in chronić rhinosinusitis and decreases following successful endoscopic sinus surgery. Int Forum Allergy Rhinol, 2, 471–476.
